Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2013
10/16/2013EP2648751A2 Dimeric molecular complexes with free cysteine residues and conjugates thereof
10/16/2013EP2648750A2 Antibody formulation
10/16/2013EP2648749A2 Novel modulators and methods of use
10/16/2013EP2648748A1 Novel modulators and methods of use
10/16/2013EP2648747A1 Antitumor combinations containing antibodies recognizing specifically cd38 and bortezomib
10/16/2013EP2648746A1 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
10/16/2013EP2648745A1 Compositions and methods for vaccinating cattle
10/16/2013EP2648744A2 Malaria vaccines based on pre-erythrocytic antigens from p. falciparum
10/16/2013EP2648735A2 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
10/16/2013EP2648734A1 Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer
10/16/2013EP2648719A1 Treatment of her2-positive cancer with paclitaxel and trastuzumab-mcc-dm1
10/16/2013EP2399937A9 Anti-human alpha9 integrin antibody and use thereof
10/16/2013CN103354833A Bacterial ribonucleic acid cell wall compositions and methods of making and using them
10/16/2013CN103354748A Modified hepatitis c virus proteins
10/16/2013CN103354747A Recombinant mycobacterium as a vaccine
10/16/2013CN103354746A Compositions and methods for vaccinating cattle
10/16/2013CN103352030A Vaccine comprising an attenuated pestivirus
10/16/2013CN103352029A Epidemic encephalitis B/forest encephalitis hybrid virus and application of virus
10/16/2013CN103352015A HtpsA-gene-knock-out mutant strain of Streptococcus suis serotype 2 and application thereof
10/16/2013CN103351438A Anti-cmet antibody
10/16/2013CN103351437A Lingo binding molecules and pharmaceutical use thereof
10/16/2013CN103351435A Human binding molecules having killing activity against staphylococci and uses thereof
10/16/2013CN103351423A Peptide vaccines for cancers expressing tumor-associated antigens
10/16/2013CN103349782A Preparation technology of chicken Eimeria tenella egg yolk antibody targeted sustained release preparation
10/16/2013CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties
10/16/2013CN103349780A Conjugation of streptococcal capsular saccharides
10/16/2013CN102776134B Streptococcus suis Serotype 2 (SS2 for short) double-gene deleted live vaccine and its application
10/16/2013CN102757940B Duck flavivirus and preparation and application of inactivated vaccine of duck flavivirus
10/16/2013CN102727886B Preparation method of immunostimulatory injection for livestock
10/16/2013CN102716474B Application of protein Rh054_01780 in rickettsia heilongjiangensis-resistant immune protection
10/16/2013CN102559689B Prawn complement 1q binding protein and application thereof
10/16/2013CN102558382B Method for purifying Hemophilus influenzae type b capsular polysaccharide
10/16/2013CN102504026B Full human single chain antibody capable of resisting epidermal growth-factor receptor and application thereof
10/16/2013CN102286104B Gene for encoding HPV (human papilloma virus) 6-type L2N120E7E6 fusion protein, expression vectors, method, bacteria strain and application
10/16/2013CN102172399B YncD gene knock-out vector for saimonella, preparation method thereof and prepared saimonella attenuated vaccine
10/16/2013CN102000326B Method for producing rabies vaccine for human
10/16/2013CN101969993B Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
10/16/2013CN101885778B HPV (Human Papilloma Virus) 16 type L2N120E7E6 fusion protein, gene, preparation method and application
10/16/2013CN101835489B IL-18 receptor antigen binding proteins
10/16/2013CN101711256B Antibodies against IL-25
10/16/2013CN101535344B Novel antiproliferation antibodies
10/16/2013CN101245101B Antihuman CD146 monoclone antibody, composition containing the same, and method for testing dissolubility CD146
10/15/2013US8557967 Anti-interferon-α antibodies
10/15/2013US8557957 Methods of treating disorders by administration of F11 receptor antagonists
10/15/2013US8557955 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
10/15/2013US8557780 Monomethylvaline compounds capable of conjugation to ligands
10/15/2013US8557579 Screening for modulators of PSGL-1 with respect to T cell or NK cell death
10/15/2013US8557533 Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4
10/15/2013US8557288 Hydrogel microparticle formation in aqueous solvent for biomedical applications
10/15/2013US8557258 Vaccines comprising TB10.4
10/15/2013US8557257 Mycobacterial immunotherapy for cancer treatment
10/15/2013US8557256 Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin
10/15/2013US8557255 High frequency application of botulinum toxin therapy
10/15/2013US8557254 Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel Lawsonia intracellularis serotype and hybridomas for producing the said antibodies
10/15/2013US8557253 Stabilizing excipient for inactivated whole virus vaccine
10/15/2013US8557252 Genetically stable attenuated polioviruses comprising multiple mutations in domain V of the 5′ noncoding region
10/15/2013US8557251 Non-live trivalent influenza vaccine for one-dose intradermal delivery
10/15/2013US8557250 Methods for preparing complex multivalent immunogenic conjugates
10/15/2013US8557248 Methods and compositions for treating malaria
10/15/2013US8557247 Lyophilised antigen composition
10/15/2013US8557245 Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
10/15/2013US8557244 Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
10/15/2013US8557241 Secreted/cell bound poxvirus proteins and methods of use thereof as vaccines and anti-viral agents
10/15/2013US8557240 Method for the treatment of inflammatory disorders
10/15/2013US8557239 Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23
10/15/2013US8557238 EG-VEGF nucleic acids and polypeptides and methods of use
10/15/2013US8557233 Probiotic bifidobacterium strains
10/15/2013US8557232 Stabilization of Fc-interferon-beta fusion proteins
10/15/2013US8557231 Biodegradable poly(beta-amino esters) and uses thereof
10/15/2013CA2634480C Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof
10/15/2013CA2573702C Vaccine constructs and combination of vaccines designed to improve the breadth of the immune response to diverse strains and clades of hiv
10/15/2013CA2568364C Methods for preparing immunogenic conjugates
10/15/2013CA2555699C Monoclonal antibody based biomarker discovery and development platform
10/15/2013CA2555013C Carcinoembryonic antigen fusions and uses thereof
10/15/2013CA2548942C Anti-sars monoclonal antibodies
10/15/2013CA2544562C Bispecific antibodies
10/15/2013CA2533926C Methods and compositions for producing antigenic responses
10/15/2013CA2494844C Methods and compositions concerning poxviruses and cancer
10/15/2013CA2463827C Methods and compositions for controlled release of bioactive compounds
10/15/2013CA2452119C Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof
10/15/2013CA2380108C Recombinant rsv virus expression systems and vaccines
10/15/2013CA2373721C Compounds that bind her2
10/15/2013CA2330178C Synthetic peptide vaccines for foot-and-mouth disease
10/15/2013CA2296434C Mutations in the myostatin gene cause double-muscling in mammals
10/10/2013WO2013152352A1 Live, attenuated rubella vector to express vaccine antigens
10/10/2013WO2013152351A2 Fusion polypeptides and methods of use thereof
10/10/2013WO2013152313A1 Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
10/10/2013WO2013152274A1 Epitope- scaffold immunogens against respiratory syncytial virusm (rsv)
10/10/2013WO2013152252A1 Combination anti-cancer therapy
10/10/2013WO2013152092A1 Soluble microneedle arrays for buccal delivery of vaccines
10/10/2013WO2013152086A1 Pcv/mycoplasma hyopneumoniae/prrs combination vaccine
10/10/2013WO2013152083A2 Pcv/mycoplasma hyopneumoniae combination vaccine
10/10/2013WO2013152081A1 Mycoplasma hyopneumoniae vaccine
10/10/2013WO2013152034A1 Dosage and administration of monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
10/10/2013WO2013152024A1 Humanized and chimeric anti-factor c3 antibodies and uses thereof
10/10/2013WO2013152020A1 Humanized and chimeric anti-factor bb antibodies and uses thereof
10/10/2013WO2013151979A1 Outer membrane proteins of histophilus somni and methods thereof
10/10/2013WO2013151764A1 Methods and compositions for dengue virus epitopes
10/10/2013WO2013151731A1 Recombinant bacterium for induction of cellular immune response
10/10/2013WO2013151706A2 Subunit vaccine delivery platform for robust humoral and cellular immune responses
1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 1823